Hat mitgewirkt an:
-
Phase 1 first-in-human trial of the anti-CD37 antibody BI 836826 in relapsed/refractory chronic lymphocytic leukemia
-
Verordnungsverhalten niedergelassener Ärzte bei der Therapie von Tumorschmerzen : eine dreijährige Untersuchung in 330 Praxen
-
Viral transduction of primary human lymphoma B cells reveals mechanisms of NOTCH-mediated immune escape
-
Large B-cell lymphomas with CCND1 rearrangement have different immunoglobulin gene breakpoints and genomic profile than mantle cell lymphoma